uric acid has been researched along with norathyriol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, GH; Gao, LH; Li, L; Liu, HY; Liu, J; Liu, X; Niu, Y | 1 |
| Gao, L; Li, F; Li, L; Li, N; Lin, H; Niu, Y; Tu, C; Xu, A; Yuan, L | 1 |
2 other study(ies) available for uric acid and norathyriol
| Article | Year |
|---|---|
Hypouricaemic action of mangiferin results from metabolite norathyriol via inhibiting xanthine oxidase activity.
Topics: Administration, Oral; Animals; Biomarkers; Biotransformation; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Enzyme Inhibitors; Gout Suppressants; Hyperuricemia; Kinetics; Mice; Molecular Structure; Oxonic Acid; Structure-Activity Relationship; Uric Acid; Xanthenes; Xanthine Oxidase; Xanthones | 2016 |
Dual actions of norathyriol as a new candidate hypouricaemic agent: uricosuric effects and xanthine oxidase inhibition.
Topics: Animals; Enzyme Inhibitors; HEK293 Cells; Humans; Hyperuricemia; Kidney; Mice; Organic Anion Transport Protein 1; Organic Anion Transporters; Uric Acid; Xanthenes; Xanthine Oxidase | 2019 |